BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Cortex Pharmaceuticals, Inc.'s Studies in Animals Demonstrate AMPAKINE Molecules Reverse Memory Loss in Huntington’s Disease

  March 6, 2009

   · 

  1 min read
• Drug Development

  Sepracor, Inc. Reports Preliminary Phase II Study Results for SEP-225441 for the Treatment of Generalized Anxiety Disorder

  March 6, 2009

   · 

  1 min read
• Skyepharma PLC Announces Conversion of Bonds

  March 6, 2009

   · 

  1 min read
• Pharm Country

  Small Bone Innovations, Inc. Increases Donation to Limb Salvage Centers of Devices from $500,000 to $1.2 Million

  March 6, 2009

   · 

  1 min read
• Policy

  Transgenomic, Inc. Awarded Clinical Laboratory Certification in California

  March 6, 2009

   · 

  3 min read
• Business

  Cytori Therapeutics, Inc. Reports Year End 2008 Results; Reviews 2008 Progress and 2009 Business Objectives

  March 6, 2009

   · 

  1 min read
• Business

  AEterna Zentaris and Sanofi-Aventis (France) Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia; Sanofi-Aventis To Make Initial $30 Million Upfront Payment

  March 6, 2009

   · 

  6 min read
• Business

  Novartis Corporation Announces 30% Increase in 2008 China Revenues

  March 6, 2009

   · 

  1 min read
• MediSys Corporation Launches New Web Site

  March 6, 2009

   · 

  2 min read
• Business

  Peplin Inc.’s Positive Phase IIb AK Trial Result Details

  March 6, 2009

   · 

  1 min read